Oncology Based Preclinical CRO Market
Oncology Based Preclinical CRO Market Scope:
Industry Analysis, Market Size, Growth, Trends Till
2031
Request Sample Report
Oncology Based Preclinical CRO Market Size and Growth
The oncology-based preclinical CRO market is experiencing robust growth, driven by increasing cancer research and development investments. The market size is projected to reach approximately $5 billion by 2026, fueled by advancements in personalized medicine and innovative drug development strategies. Competitive dynamics are intensifying as demand for specialized services escalates. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Crown Bioscience
◍ Charles River
◍ ICON
◍ Eurofins Scientific
◍ Taconic Biosciences
◍ Covance
◍ EVOTEC
◍ The Jackson Laboratory
◍ MI Bioresearch
◍ Champion Oncology
◍ Wuxi AppTec.
◍ Xentech
◍ Living Tumor Laboratory
The Oncology-Based Preclinical CRO market features companies such as Crown Bioscience, Charles River, ICON, and Eurofins Scientific, which provide essential services like tumor model development, drug efficacy testing, and biomarker analysis. These companies enable drug discovery and development efficiencies, driving market growth through innovative solutions and expanding service portfolios.
Sales Revenue (approx.):
- Charles River: $3.3 billion
- Covance: $1.6 billion
- Wuxi AppTec: $3 billion Request Sample Report
Market Segmentation
By Application
In Vitro
In Vivo
Request Sample Report
By Product
Blood Cancer
Solid Tumors
Others
Market Growth
Request Sample Report
$ X Billion USD
